Clinical Trial Detail

NCT ID NCT03014648
Title Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: senior adult

No variant requirements are available.